Ignite Creation Date:
2025-12-24 @ 5:06 PM
Ignite Modification Date:
2026-01-29 @ 6:00 PM
Study NCT ID:
NCT01170650
Status:
TERMINATED
Last Update Posted:
2021-09-30
First Post:
2010-07-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)
Sponsor:
Endocyte
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
8109-002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None